z-logo
open-access-imgOpen Access
Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours
Author(s) -
Cathérine Uzan,
E. Muller,
Aminata Kane,
Sébastien Gouy,
Sofiane Bendifallah,
R. Fauvet,
Émile Daraï,
Philippe Morice
Publication year - 2013
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/det371
Subject(s) - medicine , serous fluid , fertility , stage (stratigraphy) , pregnancy , surgery , disease , ovary , ovarian carcinoma , ovarian cancer , gynecology , cancer , population , paleontology , genetics , environmental health , biology
Here we report the outcomes of 26 patients who relapsed following conservative surgical treatment of stage I serous borderline ovarian tumours treated initially with fertility-sparing surgery. All recurrences were diagnosed by systematic ultrasonography during follow-up. Eleven patients relapsed at least twice after such management. Twenty-one pregnancies were observed in 13 patients. Eleven of these patients became pregnant after the treatment of their first recurrence. All patients had a borderline ovarian tumour and/or non-invasive peritoneal implants at the time of the first recurrence but two of them had invasive ovarian and peritoneal disease at the time of the second or third recurrence (one of them died of disease). Fertility-preserving surgery remains a valuable alternative (if technically feasible), in young patients with recurrent SBOT, in the form of a non-invasive ovarian lesion, who wish to start a pregnancy. However, it should be associated with meticulous follow-up because the risk of progression to carcinoma exists, albeit small.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom